HCWB
Income statement / Annual
Last year (2024), HCW Biologics Inc.'s total revenue was $2.57 M,
a decrease of 9.68% from the previous year.
In 2024, HCW Biologics Inc.'s net income was -$30.02 M.
See HCW Biologics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.57 M |
$2.84 M |
$6.72 M |
$0.00 |
$4.10 M |
$0.00 |
| Cost of Revenue |
$1.61 M
|
$2.28 M
|
$4.14 M
|
$543.60 K
|
$0.00
|
$421.82 K
|
| Gross Profit |
$959.40 K
|
$560.36 K
|
$2.59 M
|
-$543.60 K
|
$4.10 M
|
-$421.82 K
|
| Gross Profit Ratio |
0.37
|
0.2
|
0.38
|
0
|
1
|
0
|
| Research and Development Expenses |
$6.39 M
|
$7.68 M
|
$9.34 M
|
$8.17 M
|
$7.26 M
|
$5.39 M
|
| General & Administrative Expenses |
$6.84 M
|
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Selling & Marketing Expenses |
-$804.86 K
|
$245.61 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.03 M
|
$13.08 M
|
$8.33 M
|
$4.98 M
|
$2.44 M
|
$1.80 M
|
| Other Expenses |
$18.02 M
|
$5.52 M
|
$304.74 K
|
$218.47 K
|
$233.04 K
|
$171.42 K
|
| Operating Expenses |
$28.83 M
|
$21.03 M
|
$17.67 M
|
$13.37 M
|
$9.92 M
|
$7.37 M
|
| Cost And Expenses |
$30.44 M
|
$28.56 M
|
$21.80 M
|
$13.37 M
|
$9.92 M
|
$7.37 M
|
| Interest Income |
$0.00
|
$0.00
|
$126.66 K
|
$505.37 K
|
$22.32 K
|
$72.35 K
|
| Interest Expense |
$1.16 M
|
$283.04 K
|
$126.66 K
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.18 M
|
$1.14 M
|
$589.61 K
|
$543.60 K
|
$572.87 K
|
$421.82 K
|
| EBITDA |
-$27.68 M |
-$23.58 M |
-$14.18 M |
-$12.82 M |
-$5.25 M |
-$6.94 M |
| EBITDA Ratio |
-10.78
|
-8.3
|
-2.11
|
0
|
-1.28
|
0
|
| Operating Income Ratio |
-11.49
|
-9.05
|
-2.24
|
0
|
-1.42
|
0
|
| Total Other Income/Expenses Net |
-$544.15 K
|
$722.88 K
|
$178.08 K
|
$505.37 K
|
$22.32 K
|
$72.35 K
|
| Income Before Tax |
-$30.02 M
|
-$24.99 M
|
-$14.90 M
|
-$12.86 M
|
-$5.80 M
|
-$7.29 M
|
| Income Before Tax Ratio |
-11.7
|
-8.8
|
-2.22
|
0
|
-1.42
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$178.08 K
|
-$505.37 K
|
-$22.32 K
|
-$72.35 K
|
| Net Income |
-$30.02 M
|
-$24.99 M
|
-$14.72 M
|
-$12.36 M
|
-$5.78 M
|
-$7.22 M
|
| Net Income Ratio |
-11.7
|
-8.8
|
-2.19
|
0
|
-1.41
|
0
|
| EPS |
-0.77 |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| EPS Diluted |
-0.77 |
-0.7 |
-0.41 |
-0.35 |
-0.16 |
-0.2 |
| Weighted Average Shares Out |
$38.79 M
|
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Weighted Average Shares Out Diluted |
$38.79 M
|
$35.93 M
|
$35.82 M
|
$35.77 M
|
$36.70 M
|
$36.70 M
|
| Link |
|
|
|
|
|
|
